Literature DB >> 23179191

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Odey C Ukpo1, Wade L Thorstad, James S Lewis.   

Abstract

Human papillomavirus (HPV) is associated with oropharyngeal squamous cell carcinomas. Persistent viral infection is postulated to lead to carcinogenesis, although infection of benign adjacent epithelium is not typically observed. It is known that immune evasive tumor cells can provide an ideal niche for a virus. The B7-H1/PD-1 cosignaling pathway plays an important role in viral immune evasion by rendering CD8+ cytotoxic T cells anergic. We hypothesized that HPV-related oropharyngeal squamous cell carcinomas express B7-H1 as a mechanism for immune evasion. A tissue microarray was utilized, for which HPV E6/E7 mRNA by in situ hybridization was previously performed. Immunohistochemistry was performed to detect B7-H1 and staining was characterized by pattern, distribution, and intensity. B7-H1 was expressed by 84 of the 181 (46.4%) cases. Both tumor cell membranous and cytoplasmic expression were present and cytoplasmic expression was identified in some peritumoral lymphocytes. Expression was analyzed in several different ways and then considered binarily as positive versus negative. Tumors expressing B7-H1 were more likely to be HPV positive (49.2 vs. 34.1 %, p = 0.08). B7-H1 expression showed no correlation with disease recurrence in the entire cohort (OR = 1.09, p = 0.66), HPV positive cohort (OR = 0.80, p = 0.69) or HPV negative cohort (OR = 2.02, p = 0.22). However, B7-H1 expression intensity did correlate with the development of distant metastasis (p = 0.03), and B7-H1 intensity of 3+ (versus all other staining) showed a strong trend towards distant metastasis in the HPV positive (OR = 6.67, p = 0.13) and HPV negative (OR = 9.0, p = 0.13) cohorts. There was no correlation between B7-H1 expression and patient survival for any of the different ways in which staining was characterized, whether binarily, by distribution, intensity, or combined scores. B7-H1 is expressed in the majority of oropharyngeal squamous cell carcinomas with transcriptionally-active HPV. This suggests that B7-H1 expression by tumor cells may play a role in harboring persistent HPV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179191      PMCID: PMC3642256          DOI: 10.1007/s12105-012-0406-z

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  39 in total

1.  Prevalence of oral HPV infection in the United States, 2009-2010.

Authors:  Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi
Journal:  JAMA       Date:  2012-01-26       Impact factor: 56.272

2.  High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults.

Authors:  Anaëlle Duray; Géraldine Descamps; Marie Bettonville; Nicolas Sirtaine; Perle Ernoux-Neufcoeur; Samuel Guenin; Mustapha Mouallif; Christophe E Depuydt; Philippe Delvenne; Sven Saussez
Journal:  Otolaryngol Head Neck Surg       Date:  2011-08       Impact factor: 3.497

3.  High prevalence of human papillomavirus type 16 infection among children.

Authors:  P S Rice; C Mant; J Cason; J M Bible; P Muir; B Kell; J M Best
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

4.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

5.  Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.

Authors:  Daniel C Beachler; Kathleen M Weber; Joseph B Margolick; Howard D Strickler; Ross D Cranston; Robert D Burk; Dorothy J Wiley; Howard Minkoff; Susheel Reddy; Emily E Stammer; Maura L Gillison; Gypsyamber D'Souza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-01       Impact factor: 4.254

6.  Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.

Authors:  Jie Chen; Guosheng Li; Hong Meng; Yuchen Fan; Yonghong Song; Shurong Wang; Faliang Zhu; Chun Guo; Lining Zhang; Yongyu Shi
Journal:  Cancer Immunol Immunother       Date:  2011-08-19       Impact factor: 6.968

7.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Authors:  Paul M Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Janet Brandsma; Clarence Sasaki; John Joe; Robert L Camp; David L Rimm; Amanda Psyrri
Journal:  J Clin Oncol       Date:  2006-01-09       Impact factor: 44.544

8.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

9.  Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.

Authors:  Shahnaz Begum; Maura L Gillison; Theresa L Nicol; William H Westra
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

10.  Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

Authors:  Christian Blank; Juergen Kuball; Simon Voelkl; Heinz Wiendl; Bernd Becker; Bernhard Walter; Otto Majdic; Thomas F Gajewski; Mathias Theobald; Reinhard Andreesen; Andreas Mackensen
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

View more
  54 in total

1.  Spatial Intratumoral Heterogeneity Expression of PD-L1 Antigen in Head and Neck Squamous Cell Carcinoma.

Authors:  Nir Hirshoren; Issa Al-Kharouf; Jeffrey M Weinberger; Ron Eliashar; Aron Popovtzer; Ariela Knaanie; Yakov Fellig; Tzahi Neuman; Karen Meir; Alexander Maly; Gilad W Vainer
Journal:  Oncology       Date:  2021-03-31       Impact factor: 2.935

Review 2.  Molecular biology and immunology of head and neck cancer.

Authors:  Theresa Guo; Joseph A Califano
Journal:  Surg Oncol Clin N Am       Date:  2015-04-20       Impact factor: 3.495

Review 3.  AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.

Authors:  Cory D Fulcher; Missak Haigentz; Thomas J Ow
Journal:  Head Neck       Date:  2017-11-24       Impact factor: 3.147

4.  Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Theresa Scognamiglio; Yao-Tseng Chen
Journal:  Head Neck Pathol       Date:  2017-09-25

5.  A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dan P Zandberg; Sandra Rollins; Olga Goloubeva; Robert E Morales; Ming Tan; Rodney Taylor; Jeffrey S Wolf; Lisa M Schumaker; Kevin J Cullen; Ann Zimrin; Robert Ord; Joshua E Lubek; Mohan Suntharalingam; John C Papadimitriou; Dean Mann; Scott E Strome; Martin J Edelman
Journal:  Cancer Immunol Immunother       Date:  2014-12-24       Impact factor: 6.968

6.  The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments.

Authors:  Sophie Outh-Gauer; Aurélien Morini; Eric Tartour; Charles Lépine; Alain C Jung; Cécile Badoual
Journal:  Head Neck Pathol       Date:  2020-03-02

7.  Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.

Authors:  Dan Ou; Julien Adam; Ingrid Garberis; Pierre Blanchard; France Nguyen; Antonin Levy; Odile Casiraghi; Philippe Gorphe; Ingrid Breuskin; François Janot; Stephane Temam; Jean-Yves Scoazec; Eric Deutsch; Yungan Tao
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

8.  An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.

Authors:  A E Rice; Y E Latchman; J P Balint; J H Lee; E S Gabitzsch; F R Jones
Journal:  Cancer Gene Ther       Date:  2015-09-04       Impact factor: 5.987

Review 9.  Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Authors:  Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

10.  Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.

Authors:  Fernando Concha-Benavente; Raghvendra M Srivastava; Sumita Trivedi; Yu Lei; Uma Chandran; Raja R Seethala; Gordon J Freeman; Robert L Ferris
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.